Rapid Detection Device for Feline Parvovirus Antigen: CRP C-Reactive Protein Semi-Quantitative Test
Introducing QL Biotech’s top-of-the-line product - the CRP C-Reactive Protein Semi-Quantitative Rapid Test Device. This unique and sophisticated product aids in the rapid detection of feline parvovirus antigen, a significant cause of fever and severe illness in our beloved feline companions.
Aimed at professional in vitro diagnostic use, our test device is designed to return accurate results with the least possible margin of error. It provides a range of 10~30~60 mg/L, ensuring the prompt identification of the feline parvovirus antigen even at its early stages. With this product, our goal at QL Biotech is to help veterinary professionals make accurate and timely decisions related to the health and wellbeing of cats.
Our CRP C-Reactive Protein Semi-Quantitative Rapid Test Device is not just a tool; it's a robust system that represents our commitment to advanced technological solutions in the veterinary field. It has been carefully crafted based on years of research and development efforts at QL Biotech, prioritizing user-friendliness without compromising on accuracy and reliability.
Please note that as part of our commitment to ensuring reliable outcomes and adhering to best practices, this device is strictly for professional in vitro diagnostic use only. We encourage all users to adhere to precautions while using the device. With the QL Biotech CRP C-Reactive Protein Semi-Quantitative Rapid Test Device, the detection of feline parvovirus antigen becomes a swift, efficient, and reliable process. Invest in this invaluable tool for ensuring feline health today.
PRECAUTIONS
For professional in vitro diagnostic use only.
Do not use after the expiration date indicated on the package. Do not use the test if the foil pouch is damaged. Do not reuse tests.- This kit contains products of animal origin. Certified knowledge of the origin and/or sanitary state of the animals does not completely guarantee the absence of transmissible pathogenic agents. It is therefore recommended that these products be treated as potentially infectious, and handled observing usual safety precautions (e.g., do not ingest or inhale).
- Avoid cross‐contamination of specimens by using a new specimen collection container for each specimen obtained.
- Read the entire procedure carefully prior to any testing.
- Do not eat, drink or smoke in the area where the specimens and kits are handled. Handle all specimens as if they contain infectious agents. Observe established precautions against microbiological hazards throughout the procedure and follow standard procedures for proper disposal of specimens. Wear protective clothing such as laboratory coats, disposable gloves and eye protection when specimens are assayed.
- Do not interchange or mix reagents from different lots.
- Humidity and temperature can adversely affect results.
- Used testing materials should be discarded in accordance with local regulations.
INTERPRETATION OF RESULTS
POSITIVE RESULT: Possible Interpretation of CRP Levels
NOTE:
- The intensity of the color in the test region (T) may vary depending on the concentration of analytes present in the specimen. Therefore, any shade of color in the test region should be considered positive. Please note that this is a semi‐quantitative test only, and cannot determine the concentration of analytes in the specimen.
- Insufficient specimen volume, incorrect operating procedure or expired tests are the most likely reasons for control band failure.
INTENDED USE
-
The CrP Rapid Test Device (Whole Blood/Serum/Plasma) is used for semi‐quantitative determination and monitoring of CrP concentrations in whole blood/serum/plasma specimens.
C‐reactive Protein (CrP) in patient’s sera has been found in association with acute infections, necrotic conditions and a variety of inflammatory disorders. There is a strong correlation between serum levels of CrP and the onset of the inflammatory process. Monitoring the levels of CrP in
patient’s sera indicates the effectiveness of treatment and the assessment of patient recovery. It is used in particular to differentiate bacterial infections from virus infections.
Please note that as part of our commitment to ensuring reliable outcomes and adhering to best practices, this device is strictly for professional in vitro diagnostic use only. We encourage all users to adhere to precautions while using the device. With the QL Biotech CRP C-Reactive Protein Semi-Quantitative Rapid Test Device, the detection of feline parvovirus antigen becomes a swift, efficient, and reliable process. Invest in this invaluable tool for ensuring feline health today.